Ozanimod for treating relapsing-remitting multiple sclerosis [ID1294]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 12 February 2021.
Search results
4 results
-
-
Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (CDF Review TA490) [ID1585]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 28 January 2021.
-
Anakinra for treating active Stills disease [ID1463]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 27 January 2021.
-
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma [ID1589]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 11 February 2021.